| Turchia | Austria | Spagna | |
| NanoKnife | da $9,500 | da $25,000 | da $12,000 |
| CyberKnife | da $4,750 | da $50,000 | da $30,000 |
| Actinium-225 Therapy | da $20,500 | da $55,000 | da $45,000 |
| Enucleation of tumor on pancreas | da $10,000 | - | - |
Revisionato medicalmente da
Fahad MawloodBookimed non aggiunge costi extra ai prezzi dei trattamenti di Pancreatic neuroendocrine tumors. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Pancreatic neuroendocrine tumors e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Pancreatic neuroendocrine tumors.
Prof. Christoph Zielinski founded Vienna's Comprehensive Cancer Center – a leader in personalized oncology treatments combining immunotherapy and tumor biology.
Prof. Köstler is an internationally recognized authority in precision oncology, focusing on targeted cancer therapies and immunotherapy at Wiener Privatklinik.
Dr. Klaus Kaczirek is a senior physician at the University Clinic for Surgery, Medical University of Vienna. He specializes in general and visceral surgery. He is known for his skill in hepatobiliopancreatic, oncological visceral, and endocrine surgery. His main focus is on complex operations involving the liver, pancreas, gastrointestinal tract, and endocrine organs.
Dr. Kaczirek holds board certifications in both general and visceral surgery. Since 2008, he has led the liver, gallbladder, and pancreas working group at the Austrian Society for Surgical Oncology. He is a member of the Austrian Society for Surgery, the European Society of Endocrine Surgeons, and other international surgical organizations. Dr. Kaczirek also reviews articles for leading medical journals and has helped advance surgical oncology and endocrine surgery.